Docosatetraenoylethanolamide
Docosatetraenoylethanolamide (also known as DTEA or 22:4n-6 ethanolamide) is a polyunsaturated fatty acid (PUFA) ethanolamide. It is a member of the N-acylethanolamines (NAEs) family, which are bioactive lipids. DTEA is derived from adrenic acid, a PUFA that is abundant in the human brain and other nervous tissues.
Structure and Properties
DTEA is a long-chain fatty acid ethanolamide. Its structure consists of a 22-carbon chain with four double bonds (22:4), hence the name 22:4n-6 ethanolamide. The "n-6" indicates that the first double bond is located at the sixth carbon from the methyl end of the fatty acid chain.
Biosynthesis and Metabolism
DTEA is synthesized from adrenic acid through the action of the enzyme N-acyltransferase (NAT). This enzyme catalyzes the transfer of the adrenic acid to ethanolamine, forming DTEA. The metabolism of DTEA is primarily carried out by the enzyme fatty acid amide hydrolase (FAAH), which hydrolyzes DTEA into adrenic acid and ethanolamine.
Biological Functions
The biological functions of DTEA are not fully understood. However, it is known that DTEA and other NAEs play important roles in various physiological processes, including inflammation, pain perception, appetite regulation, and neuroprotection. DTEA has been found to exhibit anti-inflammatory and neuroprotective effects in experimental models.
Research and Clinical Significance
Research on DTEA is still in its early stages. However, due to its potential roles in inflammation, pain perception, and neuroprotection, DTEA is of interest in the study of various neurological and inflammatory diseases. Further research is needed to fully understand the biological functions and therapeutic potential of DTEA.
See Also
- N-acylethanolamines
- Adrenic acid
- Polyunsaturated fatty acid
- N-acyltransferase
- Fatty acid amide hydrolase
This article is a biochemistry stub. You can help WikiMD by expanding it!
This article is a neuroscience stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD